干燥综合征临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 干燥综合征（国际通用名 Sjogren syndrome）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。
正在招募的干燥综合征新药试验
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
不适用招募中中国NCT06614270The Myelin Disorders Biorepository Project
不适用招募中美国NCT03047369TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
IV 期招募中BrazilNCT07153276AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
II 期招募中美国BrazilBulgaria法国NCT06991114Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
不适用招募中中国NCT05605314Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
不适用招募中NorwayNCT06732674Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
不适用招募中西班牙NCT07249060Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
I 期 / II 期招募中中国NCT06947473Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
IV 期招募中美国NCT07277257CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
I 期 / II 期招募中中国NCT06947460Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
II 期招募中美国NCT07281456Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
I 期招募中中国NCT07184450
干燥综合征试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。
查看四条路径与写信模板